Cita APA (7a ed.)

Davenport, A. J., Neagoe, I., Bräuer, N., Koch, M., Rotgeri, A., Nagel, J., . . . Fischer, O. M. (2021). Eliapixant is a selective P2X3 receptor antagonist for the treatment of disorders associated with hypersensitive nerve fibers. Nature Portfolio.

Cita Chicago Style (17a ed.)

Davenport, Adam J., et al. Eliapixant Is a Selective P2X3 Receptor Antagonist for the Treatment Of disorders associated With hypersensitive nerve Fibers. Nature Portfolio, 2021.

Cita MLA (8a ed.)

Davenport, Adam J., et al. Eliapixant Is a Selective P2X3 Receptor Antagonist for the Treatment Of disorders associated With hypersensitive nerve Fibers. Nature Portfolio, 2021.